In the first year of her Ph.D. program at UC Davis, Angela Courtney’s studies and life took a turn. She was diagnosed with breast cancer, and became passionate about detecting it early.READ MORE: Brazen Thieves Caught On Video Ripping Off Deer Valley High Camera Equipment
“We need to look at diagnosing and screening for breast cancer in a different way. Mammograms have saved a lot of lives but they have some challenges as well,” Courtney told KCBS.READ MORE: Worker Shortage Lingers As San Francisco Restaurants Attempt To Recover From COVID Fiscal Woes
She started a company, Adrastia Biotech, to commercialize a urine test that scans for protein and genomic material that can indicate breast cancer.
Courtney doesn’t expect it will replace mammograms, but it could be considered a less expensive, lower risk supplement to x-ray that’s easier to administer.MORE NEWS: Colorful, Dramatic Atmospheric Performance At de Young Museum Wows Crowd
“It should be something that would be part of every woman’s … yearly physical. In remote areas, those samples can be mailed in securely so that we can run the testing,” she said.